|
First electronic product information (ePI) published for selected human medicines
|
17 November 2023 |
|
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
|
31 March 2022 |
|
EMA: Human medicines highlights of 2021
|
18 February 2022 |
|
ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
|
06 September 2021 |
|
AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
|
07 April 2021 |
|
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
|
29 March 2021 |
|
EMA's safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events
|
15 March 2021 |
|
EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU
|
11 March 2021 |
|
EMA starts rolling review of the Sputnik V COVID-19 vaccine
|
08 March 2021 |
|
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
|
12 January 2021 |
|
Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
|
15 December 2020 |
|
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
|
01 December 2020 |
|
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine
|
01 December 2020 |
|
EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation
|
30 September 2020 |
|
Global regulators commit to cooperate on observational research in the context of COVID-19
|
21 May 2020 |
|
First vaccine to protect against Ebola
|
28 October 2019 |
|
EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US
|
29 August 2019 |
|
EMA to relocate to Amsterdam, the Netherlands
|
22 November 2017 |
|
Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions
|
29 May 2017 |
|
Launch of PRIME - Paving the way for promising medicines for patients
|
10 March 2016 |